Mersana Therapeutics - Stock Price History | MRSN

Historical daily share price chart and data for Mersana Therapeutics since 2021 adjusted for splits. The latest closing stock price for Mersana Therapeutics as of September 27, 2021 is 9.84.
  • The all-time high Mersana Therapeutics stock closing price was 27.59 on December 23, 2020.
  • The Mersana Therapeutics 52-week high stock price is 29.09, which is 195.6% above the current share price.
  • The Mersana Therapeutics 52-week low stock price is 8.46, which is 14% below the current share price.
  • The average Mersana Therapeutics stock price for the last 52 weeks is 17.20.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Mersana Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 15.8535 5.3600 27.5900 4.4100 26.6100 364.40%
2019 3.8775 4.3100 7.3000 1.4500 5.7300 40.44%
2018 13.2677 17.3900 22.6800 3.4500 4.0800 -75.17%
2017 16.5393 14.0000 19.9000 13.2700 16.4300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.706B $0.001B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29